Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
20
Trial Sponsor
Clinical Trial Start Date
October 29, 2021
0Primary Completion Date
September 16, 2022
0Study Completion Date
September 23, 2022
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
BCX99300
Interventional Trial Phase
Phase 20
Official Name
An Open-Label, Safety, Tolerability, and Proof-of-Concept Study of Oral BCX9930 Therapy in Subjects With C3G, IgAN, or PMN0
Last Updated
January 23, 2023
0Allocation Type
Non-Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Study summary
The purpose of this study is to determine the safety and therapeutic potential of BCX9930 in participants with C3G, IgAN, or PMN.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
